NCT01016327View on ClinicalTrials.gov

Study of NMS-1116354 in Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

September 30, 2012

Conditions
Advanced Solid Tumors
Interventions
DRUG

NMS-1116354

Oral daily administration for 7 consecutive days every 14 days

Trial Locations (1)

78229

South Texas Accelerated Research Therapeutics (START), San Antonio

Sponsors
All Listed Sponsors
lead

Nerviano Medical Sciences

INDUSTRY

NCT01016327 - Study of NMS-1116354 in Solid Tumors | Biotech Hunter | Biotech Hunter